A bioconvergence study on platinum-free concurrent chemoradiotherapy for the treatment of HPV-negative head and neck carcinoma-Reference-Cited by-同舟云学术

A bioconvergence study on platinum-free concurrent chemoradiotherapy for the treatment of HPV-negative head and neck carcinoma

Published:2024-02-05 Issue:1 Volume:52 Page:122-129
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Gonnelli Alessandra¹²,Sarogni Patrizia¹^ORCID,Giannini Noemi¹²,Linsalata Stefania³,Di Martino Fabio³,Zamborlin Agata¹⁴^ORCID,Frusca Valentina¹⁵^ORCID,Ermini Maria Laura¹^ORCID,Puccini Paola²,Voliani Valerio¹⁶^ORCID,Paiar Fabiola²

Affiliation:

1. Center for Nanotechnology Innovation@NEST, Istituto Italiano di Tecnologia, Pisa, Italy

2. Radiation Oncology Unit, Pisa University Hospital “Azienda Ospedaliero-Universitaria Pisana”, Pisa, Italy

3. Unit of Medical Physics, Pisa University Hospital “Azienda Ospedaliero-Universitaria Pisana”, Pisa, Italy

4. NEST-Scuola Normale Superiore, Pisa, Italy

5. Scuola Superiore Sant’Anna, Pisa, Italy

6. Department of Pharmacy, School of Medical and Pharmaceutical Sciences, University of Genoa, Genoa, Italy

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2024.2309233

Reference36 articles.

1. Head and neck squamous cell carcinoma

2. Head and neck cancer--Part 1: Epidemiology, presentation, and prevention

3. Epidemiology of Head and Neck Squamous Cell Carcinomas: Impact on Staging and Prevention Strategies

4. Head and neck cancer

5. Haddad RI Hicks WL Hitchcock YJ et al. NCCN guidelines version 1.2023 head and neck cancers continue NCCN guidelines panel disclosures. 2022.